This article reviews the potential clinical uses of antagonists of growth-hormone-releasing hormone (GHRH) for tumor therapy. GHRH antagonists suppress the growth of various human cancer lines ...

Objective—Glucagon-like peptide 1 (GLP-1) exerts beneficial antidiabetic actions via effects on pancreatic β- and α-cells. Previous studies have focused on the improvements in β-cell function ...

SKYTROFA® (lonapegsomatropin) is now registered by the Therapeutic Goods Administration (TGA) for the treatment of paediatric growth hormone deficiency.[1] "We are delighted to have secured TGA ...

SKYTROFA® (lonapegsomatropin) is now registered by the Therapeutic Goods Administration (TGA) for the treatment of paediatric growth hormone deficiency.[1] SINGAPORE, May 29, 2025 /PRNewswire ...

From the Department of Medicine II, Johannes Gutenberg-University, Mainz, Germany, and the Heart Center, Leipzig, Germany (R.Z.). Background—We studied the effects of recombinant growth hormone (rhGH) ...

Pancreatic islets secrete multiple biologically active peptide hormones, most notably insulin, glucagon, and somatostatin (SST), but a number of recent studies have highlighted the possibility that ...

By providing real-time, precise measurements of auxin—a hormone central to plant growth and stress response—the sensor empowers farmers with earlier and more accurate insights into plant health.